MetaCap

Aspire-Lakewood Holdings Inc. (ASBP)

NASDAQ: ASBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.13-0.41 (-5.44%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ASBP stock chart

Technical analysis

Key statistics

All statistics
Market cap
$10.00M
EPS (TTM)
-$30.89
52-week range
0.11 – 9.50
Day range
7.10 – 8.12
Volume / Avg
24.03K / 29.24K
Beta
—

52-week range

$0.11$9.50

ASBP stock today

Aspire-Lakewood (ASBP) closed at $7.13 on Nov 20, down 5.44% (-$0.41), versus the S&P 500's 3.70% decline. At this level, ASBP sits in the middle of its 52-week range of $0.11 to $9.50: 24.9% below the high, set on Sep 4, 2026 and 6381.8% above the low. ASBP is up 35.0% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 83.8%.

Aspire-Lakewood has posted a net loss over the last twelve months (EPS of -$30.89), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Aspire-Lakewood

Company profile

Aspire-Lakewood Holdings, Inc. develops sublingual drug delivery technology and manufactures automotive and industrial control systems. The company develops a nano-technology-based sublingual drug delivery system designed to enhance the pharmacokinetic performance of active pharmaceutical ingredients, supplements, and nutraceuticals to increase bioavailability, improve speed of onset, and reduce side effects.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Kraig T. Higginson
Headquarters
Estero, FL
IPO year
2022

Financial highlights

Full financials

In fiscal 2025, Aspire-Lakewood generated $6,202 in revenue. Aspire-Lakewood reported a net loss of $24.5 million, compared with a loss of $1.3 million a year earlier. Gross margin was -1.9% and operating margin -312016.9%.

Aspire-Lakewood annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022
Revenue$6.20K———
Growth————
Net income$-24.48M$-1.31M$4.46M$3.34M
EPS (diluted)$-16.38$-1.90——

Earnings

Earnings history
Last reported (Sep/2026)
Nov 20, 2026
EPS actual vs est.
$-48.05 vs —

Aspire-Lakewood peers

Health Care sector
ASBP peer companies
CompanyPrice% ChgMarket capCompare
RADXRadiopharm Theranostics Limited ADR0.6304-9.71%$9.90Mvs ASBP
AEONAEON Biopharma Inc. Class A0.123-7.59%$10.35Mvs ASBP
CMMBChemomab Therapeutics Ltd. ADR1.19+4.39%$9.58Mvs ASBP
BFRIBiofrontera Inc.0.53-7.02%$9.51Mvs ASBP
GDTCCytoMed Therapeutics Limited0.755-2.33%$9.01Mvs ASBP
CALCCalciMedica Inc.1.26+7.69%$8.69Mvs ASBP
OPTHOptimi Health Corp.1.51-13.71%$8.65Mvs ASBP
BIVIBioVie Inc. Class A0.80-12.07%$8.58Mvs ASBP

Indexes, lists and sector

Aspire-Lakewood stock FAQ

What is Aspire-Lakewood's stock price today?

ASBP last traded at $7.13 as of Nov 20, 4:00 PM EST, down 5.44% on the day. Prices are delayed at least 15 minutes.

Does Aspire-Lakewood pay a dividend?

No. Aspire-Lakewood does not currently pay a regular cash dividend.

Who is Aspire-Lakewood's CEO?

Mr. Kraig T. Higginson is the chief executive officer of Aspire-Lakewood Holdings Inc..

Has ASBP ever split its stock?

Yes. The most recent ASBP stock split was a 1-for-40 split on Jan 16, 2026.

What is the ASBP 52-week high?

The 52-week high for ASBP is $9.50 and the 52-week low is $0.11. The stock is currently 24.9% below its high.

Compare ASBP